TerSera's ZOLADEX LA gains Health Canada approval for breast cancer [Yahoo! Finance]
AstraZeneca PLC - American Depositary Shares (AZN)
Last astrazeneca plc - american depositary shares earnings: 2/5 04:00 pm
Check Earnings Report
US:NYSE Investor Relations:
astrazeneca.com/investor-relations.html
Company Research
Source: Yahoo! Finance
The new dosing option of ZOLADEX is aimed at pre and perimenopausal women with an increased recurrence or advanced breast cancer risk. Since 1995, a monthly dose of ZOLADEX 3.6mg has been approved for breast cancer treatment. The latest approval provides a three-month dosing alternative specifically for younger women with hormone-positive (HR+) breast cancer. The approval of the 10.8mg dosage is supported by multiple international studies that assessed the efficacy and safety of goserelin for ovarian function suppression in premenopausal patients with HR+ breast cancer. ZOLADEX LA is now approved for breast cancer treatment in 60 countries, with additional regulatory reviews in progress. It is also used to treat prostate cancer and specific benign gynaecological disorders. ZOLADEX is an injectable luteinising hormone-releasing hormone agonist (LHRHa) currently available in 125 countries. It was first approved in Canada in 1989 and comes as a 3.6 mg implant for 28-day do
Show less
Read more
Impact Snapshot
Event Time:
AZN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AZN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AZN alerts
High impacting AstraZeneca PLC - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
AZN
News
- FDA approves Amgen drug for tough-to-treat form of lung cancer [Yahoo! Finance]Yahoo! Finance
- Brainomix swings FDA clearance for its lung imaging AI software [Yahoo! Finance]Yahoo! Finance
- ‘Inhumane': Utah mom slaps drug company with lawsuit after suffering COVID vaccine trial injuries [FOX News]FOX News
- Tyson Fury and Mo Salah earn more than Europe's highest paid CEOs—but top U.S. execs trail only Cristiano Ronaldo's $260 million haul [Yahoo! Finance]Yahoo! Finance
- VCBeat Successfully Held 8th Future Healthcare Ecological Fair: China's Premier Release Platform for Innovative Medical Products [Yahoo! Finance]Yahoo! Finance
AZN
Sec Filings
- 5/16/24 - Form 6-K
- 5/15/24 - Form 6-K
- 5/7/24 - Form 6-K
- AZN's page on the SEC website